Value-Based Cancer Care Issues


April 2016, Vol 7, No 3

Oncology News – April 2016

Oncology News

In This Article NCI’s Report to the Nation: Cancer Rates Continue to Decline, Liver Cancer the Exception A New Gene Variant May Explain Cancer-Related Outcomes in African-Americans   NCI’s Report to the Nation: Cancer Rates Continue to Decline, Liver Cancer [ Read More ]

FDA News – April 2016

FDA Approvals, News & Updates

  • Xalkori Receives New Indication for Metastatic Non–Small-Cell Lung Cancer with the ROS-1 Mutation
  • Afinitor Granted New Indication for Unresectable, Locally Advanced or Metastatic Neuroendocrine Tumors
  • FDA Designates Iomab-B as Orphan Drug in the Treatment of Relapsed and/or Refractory Acute Myeloid Leukemia in Older Patients
[ Read More ]

In the Literature – April 2016

In the Literature

  • Acalabrutinib Demonstrates Efficacy and Safety in Relapsed CLL
  • Targeting BCL2 with Venetoclax in Patients with Relapsed CLL
  • Atezolizumab Shows Durable Response, Tolerability in Urothelial Carcinoma
  • Ibrutinib Superior to Chlorambucil in CLL
[ Read More ]